Inari Medical, Inc. revised revenue guidance for the full year 2022. For the full year 2022, the company revising its revenue guidance to a range of $360 million to $370 million, an increase of $10 million from its original guidance range of $350 million to $360 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
45.3 USD | -1.31% | -6.92% | -30.22% |
May. 23 | Sector Update: Health Care Stocks Lower Thursday Afternoon | MT |
May. 23 | Inari Medical Sues Imperative Care, Truvic Medical for Alleged Patent Infringement | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.22% | 2.63B | |
+75.67% | 12.57B | |
-25.35% | 7.28B | |
+15.77% | 7.2B | |
+14.52% | 5.47B | |
-19.88% | 4.73B | |
+14.91% | 4.09B | |
-23.83% | 3.78B | |
+42.93% | 2.3B | |
-0.50% | 2.03B |
- Stock Market
- Equities
- NARI Stock
- News Inari Medical, Inc.
- Inari Medical, Inc. Revises Revenue Guidance for the Full Year 2022